Eli Lilly (NYSE:LLY) is a pharmaceutical titan with an $815 billion market cap, putting it on track to be the next $1 ...

Eli Lilly and Company is leading a global effort to protect wildlife by shifting away from horseshoe crab blood and using a ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Companies are announcing significant investments in U.S. manufacturing in response to looming tariffs. An AstraZeneca ...

A recent study shows consistent users of Eli Lilly’s new weight loss drug, Zepbound, have managed to keep the weight off.

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in ...

Trial data data showed Lilly's experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer ...

Eli Lilly (NYSE:LLY) is a pharmaceutical titan ... Lilly is offsetting that with a $9 billion plant it is building in Indiana with plans to spend another $4.5 billion for a "medicine foundry ...